MAZE Maze Therapeutics Corp: Tezkor likvidlik ko‘rsatkichi

Maze Therapeutics Corp (MAZE) tovar belgisi

Maze Therapeutics Inc (MAZE) genom tahlili uchun Compass sun'iy intellektidan foydalanish va Pompe kasalligi uchun maqsadli terapiyani ishlab chiqish orqali texnologik sakrashni amalga oshirmoqda. Biznes buyrak patologiyalari va metabolik buzilishlarni davolashda shaxsiylashtirilgan yondashuvga tayanadi. Grafikdagi narx harakati, bunda ko'rsatkich 18.99 darajasida turibdi, eng yirik sog'liqni saqlash gigantlari bilan tuzilgan daromadli kelishuvlar tomonidan qo'llab-quvvatlanadigan moliyaviy barqarorlik ma'lumotlarini to'ldiradi.

Maze Therapeutics Corp (MAZE) - Shoshilinch likvidlik 01.02.2025dan 31.10.2026gacha

mazetx.com - tahliliy kesimlar va asosiy koʻrsatkichlar (MAZE)

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi Maze Tx|MAZE - Tahlilchilar konsensus prognozi
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Bozor bahosi Maze Tx|MAZE - Biznesning to‘liq qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Maze Therapeutics|MAZE - Kompaniyaning xususiy kapitali|Kapitallashuvning sof aktivlarga nisbati mazetx.com|MAZE - Aktivlarning umumiy qiymati
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Maze Therapeutics Inc|MAZE - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Maze Therapeutics|MAZE - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Maze Tx|MAZE - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Maze Therapeutics|Tezkor likvidlik koeffitsiyenti mazetx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
MAZE - Sof foyda
Kompaniyaning jamlanma tahliliyoti:Maze Tx - MAZE
mazetx.com tayyor mahsulotlari

Investorlar Maze Therapeutics Inc (MAZE) kompaniyasining past likvidlikka ega zaxiralarni hisobga olmagan holda, faqat naqd pul va debitorlik qarzlari yordamida qisqa muddatli majburiyatlarini zudlik bilan to'lash qobiliyatini baholashlari kerak. Tezkor koeffitsiyentning tarixiy tendentsiyasini tahlil qilish orqali, patentlarning tijoratlashtirilishi va arzon ommaviy ishlab chiqarishga o'tishdan oldin genetik tadqiqotlarga ulkan xarajatlarni talab qiladigan ushbu biotexnologiya kompaniyasining xavfsizlik zaxirasini aniqlash mumkin.

Raqobatdosh kompaniyalar tahlili

TEM: Tezkor likvidlik koeffitsiyenti|Qiagen Corp (QGEN) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi IONS|repligen.com - Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti RNA|CRSP - Shoshilinch likvidlik|Sema4 - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti RARE|BEAM: Tezkor likvidlik ko‘rsatkichi|sarepta.com - Oraliq likvidlik koeffitsiyenti|TWST: Tezkor likvidlik koeffitsiyenti|10x Genomics Inc - Oraliq qoplash koeffitsiyenti|NTLA (Intellia) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Stoke Corp STOK|Tezkor likvidlik BioLife Solutions, Inc. (BLFS)|WVE (wavelifesciences.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti SION (Sionna Therapeutics)|Tezkor likvidlik koeffitsiyenti Prime Medicine Inc PRME|TSHA - Tezkor likvidlik|Kritik likvidlik koeffitsiyenti QURE|MGTX: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik regenxbio.com (RGNX)|Tezkor likvidlik ko‘rsatkichi SLDB|Tezkor likvidlik koeffitsiyenti Ocugen Inc|Tezkor likvidlik ko‘rsatkichi PACB (Pacific Biosciences of California)|Oraliq likvidlik koeffitsiyenti BNTC|Tezkor likvidlik koeffitsiyenti DSGN (Design Therapeutics)|Oraliq qoplama koeffitsiyenti rocketpharma.com (RCKT)|4D Molecular Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|Lexeo Therapeutics (LXEO) - Tezkor likvidlik ko‘rsatkichi|korrobio.com (KRRO) - Tezkor likvidlik|EDIT - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi SLN|PRQR: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CDXS|Oraliq qoplama koeffitsiyenti Sangamo Therapeutics Inc.|Tezkor likvidlik Nautilus Bio NAUT|MGX: Shoshilinch likvidlik koeffitsiyenti|Precision BioSciences, Inc. - Tezkor likvidlik koeffitsiyenti|Generation Bio Co. (GBIO) - Tezkor likvidlik ko‘rsatkichi|Boundless Bio (BOLD) - Tezkor likvidlik|Tezkor likvidlik ko‘rsatkichi Exicure|IMNN (Imunon Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti RXi Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi MBIO (Mustang Bio, Inc.)|RNAZ: Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti BNGO (Bionano Genomics)|Applied DNA Sciences Inc (APDN) - Shoshilinch likvidlik|Bluebird Bio - Tezkor likvidlik koeffitsiyenti|IPA (ImmunoPrecise Antibodies) - Shoshilinch likvidlik koeffitsiyenti|Omega Therapeutics (OMGA) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti OMIC|RGLS (Regulus Therapeutics Inc.) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti Syros Pharmaceuticals Inc.|Tezkor likvidlik Codex DNA (TBIO)|Tezkor likvidlik ko‘rsatkichi TRACON Pharmaceuticals, Inc TCON|Tezkor likvidlik koeffitsiyenti UBX (Unity Biotechnology)